Medical Standards & Regulatory Compliance
Bridgeside Telehealth operates under licensed medical supervision with structured clinical evaluation and regulatory awareness.
Licensed Medical Providers
All consultations are conducted by licensed medical providers operating within their scope of practice and state licensure.
No prescriptions are issued without a physician’s evaluation.
Biochemist-Informed Protocols
Bridgeside incorporates biochemist-informed review in the development of structured telehealth protocols.
All therapies are evaluated through a clinical lens with emphasis on safety, regulatory compliance, and individualized care.
Biochemists are not licensed medical providers and do not prescribe medication.
Prescribing decisions are made solely by licensed medical providers.
Compounded Medication Information
Some therapies offered through Bridgeside may involve compounded medications prepared by licensed 503A or 503B pharmacies.
Compounded medications are not approved for the diagnosis, treatment, cure, or prevention of disease.
All risks, benefits, and alternatives are discussed during consultation.
Medical, Telehealth & Pharmacy Compliance
Peptide Therapy Disclosure
Certain peptide therapies may be considered investigational and are not FDA-approved for specific indications.
These therapies are prescribed only after individualized physician evaluation.
Information presented on this website is for educational purposes only and does not constitute medical advice.
Individual results vary.
Pharmacy Fulfillment
Prescriptions are transmitted to licensed compounding pharmacies that comply with applicable regulatory standards.
Bridgeside does not manufacture or dispense medications directly.
Telehealth & State Availability
Bridgeside provides telehealth services in accordance with applicable state and federal regulations.
Patients must be physically located in a state where providers are licensed at the time of consultation.
Availability of specific therapies may vary by state.
Transparent Pricing Commitment
Bridgeside operates with a simple pricing structure.
01
$99
Consultation
Physician evaluation
02
$300
Peptide Therapy
For the first month, including consultation
03
$250
Additional Peptides
After the first month, when clinically indicated.
04
$275 - $475
GLP-1 Programs
Depending on therapy and dosing.
No Treatment Guarantees
Bridgeside does not guarantee outcomes.
All therapies are prescribed based on clinical evaluation.
Statements on this website have not been evaluated by the FDA.
This website does not diagnose, treat, cure, or prevent disease.
Questions About Our Medical Standards?
Schedule a consultation to speak directly with a licensed provider.